|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 269.50 DKK | -0.92% |
|
-2.94% | -17.14% |
| 09/06 | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
| 09/06 | NOVO NORDISK : Deutsche Bank reiterates its Neutral rating | ZD |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 12.03x | 5.27x | -6.48x | 4.53x | 9.26x | 10.87x | 4.17% | 186B | ||
| 33.62x | 20.07x | 0.69x | 12.22x | 25.16x | 25.66x | 0.59% | 1,025B | ||
| 24.81x | 6.25x | -1.64x | 5.72x | 15.56x | 17.21x | 2.3% | 559B | ||
| 27.31x | -812.02x | 0.11x | 6.66x | 13.61x | 13.99x | 3.08% | 394B | ||
| 17.31x | 6.38x | 1.07x | 4.28x | 10.51x | 11.96x | 3.11% | 324B | ||
| 23.32x | 5.39x | 1.11x | 4.83x | 13.75x | 14.39x | 1.81% | 286B | ||
| 20.51x | 6.13x | -171.91x | 5.3x | 12.89x | 14.05x | 3.08% | 270B | ||
| 22.48x | 16.76x | 2.78x | 6.03x | 10.53x | 13.8x | 2.92% | 187B | ||
| -45.84x | 8.7x | 0.32x | 5.54x | 31.24x | 62.24x | 2.53% | 159B | ||
| 11.98x | 1.66x | 0.21x | 3.15x | 7.67x | 8.92x | 6.84% | 146B | ||
| 10.89x | 4.82x | 0.23x | 3x | 8.02x | 8.72x | 4.52% | 113B | ||
| 25.33x | 5.08x | 1.79x | 7.64x | 17.23x | 17.94x | -.--% | 112B | ||
| 11.21x | 1.22x | 1.63x | 2.22x | 7.23x | 8.02x | 5.58% | 106B | ||
| 12.26x | 4.21x | 1.16x | 2.63x | 7.74x | 8.68x | 3.65% | 102B | ||
| 24.05x | 5.47x | 1.36x | 8.19x | 15.48x | 16.19x | 1.83% | 76.66B | ||
| 44.94x | 1.12x | 0.7x | 2.63x | 9.71x | 27.52x | 3.96% | 49.78B | ||
| 32.66x | 4.41x | 1.7x | 7.2x | 23.91x | 27.12x | 0.59% | 44.88B | ||
| 15.26x | 1.24x | -0.09x | 1.47x | 6.96x | 11.62x | 0.62% | 40.49B | ||
| 17.28x | 1.72x | 4.88x | 3.18x | 12x | 13.45x | 2.4% | 39.23B | ||
| 38.16x | 18.35x | 0.17x | 6.43x | 27.88x | 27.96x | -.--% | 39.01B | ||
| Average | 18.98x | -34.39x | -8.01x | 5.14x | 14.32x | 18.02x | 2.68% | 213.02B | |
| Weighted average by Cap. | 21.75x | -66.14x | -10.71x | 6.83x | 16.30x | 18.70x | 2.38% |
- Stock Market
- Stocks
- NOVO B Stock
- Sector Novo Nordisk A/S
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















